Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Net Income (2020 - 2025)

Historic Net Income for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$2.3 million.

  • Journey Medical's Net Income rose 313.81% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.6 million, marking a year-over-year increase of 5308.68%. This contributed to the annual value of -$14.7 million for FY2024, which is 28079.42% down from last year.
  • Per Journey Medical's latest filing, its Net Income stood at -$2.3 million for Q3 2025, which was up 313.81% from -$3.8 million recorded in Q2 2025.
  • Journey Medical's 5-year Net Income high stood at $16.8 million for Q3 2023, and its period low was -$21.8 million during Q4 2021.
  • Over the past 5 years, Journey Medical's median Net Income value was -$4.1 million (recorded in 2025), while the average stood at -$5.4 million.
  • In the last 5 years, Journey Medical's Net Income plummeted by 3681034.48% in 2021 and then skyrocketed by 26655.75% in 2023.
  • Journey Medical's Net Income (Quarter) stood at -$21.8 million in 2021, then soared by 51.07% to -$10.6 million in 2022, then skyrocketed by 79.86% to -$2.1 million in 2023, then surged by 173.82% to $1.6 million in 2024, then tumbled by 246.33% to -$2.3 million in 2025.
  • Its last three reported values are -$2.3 million in Q3 2025, -$3.8 million for Q2 2025, and -$4.1 million during Q1 2025.